Gilead Sciences Inc (NAS:GILD)
$ 65.76 -0.41 (-0.62%) Market Cap: 81.93 Bil Enterprise Value: 102.76 Bil PE Ratio: 182.67 PB Ratio: 4.67 GF Score: 75/100

Gilead Sciences Inc at Evercore ISI HealthCONx Virtual Conference Transcript

Dec 02, 2021 / 07:40PM GMT
Release Date Price: $69.67 (+1.07%)
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research

Thank you, guys, for joining us. Pleasure to have the management team from Gilead with us. I always joke about it, but the last in-person event I hosted with any company -- well, actually I just did one with Lilly recently on the road in Boston and New York. But the one prior to that, pre-pandemic, was with Merdad in San Francisco. And I remember this was late February 2020, so I guess we've built up a lot of T cells during that.

Merdad V. Parsey
Gilead Sciences, Inc. - Chief Medical Officer

We can only hope, right?

Umer Raffat;Andrew D. Dickinson
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research;Gilead

That's right. Well, listen, thank you guys for being here. Let me first turn it over to you, perhaps, Andy, to kick things off. Maybe lay the top priorities you have on your mind, and we'll jump right in.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot